Corporate Governance
LCT’s Board of Directors is responsible for the corporate governance of the consolidated entity. The Board guides and monitors the company’s business on behalf of the shareholders by whom they are elected and to whom they are accountable.
LCT is in the process of implementing the Corporate Governance Policy in accordance with the best practice recommendations of the ASX Corporate Governance Council. LCT adheres to the ASX / AusBiotech Code of Best Practice for Reporting by Life Science Companies which was developed to enhance communication and understanding between companies and the investment community.
Download LCT’s Board Charter. [35kb PDF]
Download LCT’s Code of Conduct. [54kb PDF]
Download LCT’s Continuous Disclosure. [44kb PDF]
Download LCT’s Directors, employees and associates share trading. [23kb PDF]
Download LCT’s Remuneration and nomination committee. [23kb PDF]
Download LCT’s Audit risk and compliance committee. [29kb PDF]
Download LCT’s Risk Management. [21kb PDF]
Search our site
Investor Information
Our Science
LCT’s patented encapsulation technology is a world first success.
More InformationManagement Team
LCT’s global team includes independent directors with extensive biotechnology, theraputics and capital raising experience.
More InformationDIABECELL®
Natural neo-natal porcine islets encapsulated in an alginate gel and transplanted for the treatment of insulin-dependent diabetes.
More Information